Advanced search
Publication Cover
Virulence Volume 10, 2019 - Issue SI1: Autophagy in host-pathogen interactions
Submit an article Journal homepage
9,644
Views
0
CrossRef citations to date
0
Altmetric
Special Focus on Autophagy in host-pathogen interactions

Autophagy: A new strategy for host-directed therapy of tuberculosis

Seungwha PaikDepartment of Microbiology and Infection Control Convergence Research Center, Chungnam National University School of Medicine, Daejeon, Korea;Department of Medical Science, Chungnam National University School of Medicine, Daejeon, KoreaView further author information
,
Jin Kyung KimDepartment of Microbiology and Infection Control Convergence Research Center, Chungnam National University School of Medicine, Daejeon, Korea;Department of Medical Science, Chungnam National University School of Medicine, Daejeon, KoreaView further author information
,
Chaeuk ChungDivision of Pulmonary and Critical Care, Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon, KoreaView further author information
&
Eun-Kyeong JoDepartment of Microbiology and Infection Control Convergence Research Center, Chungnam National University School of Medicine, Daejeon, Korea;Department of Medical Science, Chungnam National University School of Medicine, Daejeon, KoreaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-9623-9037View further author information
ORCID Icon
Pages 448-459 | Received 10 Jul 2018, Accepted 09 Oct 2018, Published online: 02 Nov 2018

References

  • Pareja ME, Colombo MI. Autophagic clearance of bacterial pathogens: molecular recognition of intracellular microorganisms. Front Cell Infect Microbiol. 2013;3:54.
  • Bah A, Vergne I. Macrophage autophagy and bacterial infections. Front Immunol. 2017;8:1483.
  • Kolloli A, Subbian S. Host-directed therapeutic strategies for tuberculosis. Front Med (Lausanne). 2017;4:171.
  • Kimmey JM, Stallings CL. Bacterial pathogens versus autophagy: implications for therapeutic interventions. Trends Mol Med. 2016 Dec;22(12):1060–1076.
  • Kaufmann SHE, Dorhoi A, Hotchkiss RS, et al. Host-directed therapies for bacterial and viral infections. Nat Rev Drug Discov. 2018 Jan;17(1):35–56.
  • Zumla A, Maeurer M. Host-Directed therapies for tackling multi-drug resistant tuberculosis: learning from the Pasteur-Bechamp debates. Clin Infect Dis. 2015 Nov 1;61(9):1432–1438.
  • Zumla A, Rao M, Dodoo E, et al. Potential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosis. BMC Med. 2016 Jun;15(14):89.
  • Gupta A, Misra A, Deretic V. Targeted pulmonary delivery of inducers of host macrophage autophagy as a potential host-directed chemotherapy of tuberculosis. Adv Drug Deliv Rev. 2016 Jul;1(102):10–20.
  • Y GL M, Zitvogel L, Kroemer G. Autophagy and cellular immune responses. Immunity. 2013;39:211–227.
  • Klionsky DJ, Emr SD. Autophagy as a regulated pathway of cellular degradation. Science. 2000 Dec 1;290(5497):1717–1721.
  • Mizushima N, Levine B, Cuervo AM, et al. Autophagy fights disease through cellular self-digestion. Nature. 2008 Feb 28;451(7182):1069–1075.
  • Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell. 2008 Jan 11;132(1):27–42.
  • Codogno P, Meijer AJ. Autophagy and signaling: their role in cell survival and cell death. Cell Death Differ. 2005 Nov;12(Suppl 2):1509–1518.
  • Axe EL, Walker SA, Manifava M, et al. Autophagosome formation from membrane compartments enriched in phosphatidylinositol 3-phosphate and dynamically connected to the endoplasmic reticulum. J Cell Biol. 2008 Aug 25;182(4):685–701.
  • Hamasaki M, Furuta N, Matsuda A, et al. Autophagosomes form at ER-mitochondria contact sites. Nature. 2013 Mar 21;495(7441):389–393.
  • Feng Y, He D, Yao Z, et al. The machinery of macroautophagy. Cell Res. 2014 Jan;24(1):24–41.
  • Shibutani ST, Yoshimori T. A current perspective of autophagosome biogenesis. Cell Res. 2014 Jan;24(1):58–68.
  • Lata S, Schoehn G, Solomons J, et al. Structure and function of ESCRT-III. Biochem Soc Trans. 2009 Feb;37(Pt(1)):156–160.
  • Furuta N, Yoshimori T, Amano A. Mediatory molecules that fuse autophagosomes and lysosomes. Autophagy. 2010 Apr;6(3):417–418.
  • de Chastellier C. The many niches and strategies used by pathogenic mycobacteria for survival within host macrophages. Immunobiology. 2009;214(7):526–542.
  • Shin DM, Jeon BY, Lee HM, et al. Mycobacterium tuberculosis eis regulates autophagy, inflammation, and cell death through redox-dependent signaling. PLoS Pathog. 2010 Dec 16;6(12):e1001230.
  • Romagnoli A, Etna MP, Giacomini E, et al. ESX-1 dependent impairment of autophagic flux by Mycobacterium tuberculosis in human dendritic cells. Autophagy. 2012 Sep;8(9):1357–1370.
  • Levine B, Deretic V. Unveiling the roles of autophagy in innate and adaptive immunity. Nat Rev Immunol. 2007 Oct;7(10):767–777.
  • Fabri M, Realegeno SE, Jo EK, et al. Role of autophagy in the host response to microbial infection and potential for therapy. Curr Opin Immunol. 2011 Feb;23(1):65–70.
  • Songane M, Kleinnijenhuis J, Netea MG, et al. The role of autophagy in host defence against Mycobacterium tuberculosis infection. Tuberculosis (Edinb). 2012 Sep;92(5):388–396.
  • Sil P, Muse G, Martinez J. A ravenous defense: canonical and non-canonical autophagy in immunity. Curr Opin Immunol. 2017 Nov;7(50):21–31.
  • Mizushima N. Autophagy: process and function. Genes Dev. 2007 Nov 15;21(22):2861–2873.
  • Glick D, Barth S, Macleod KF. Autophagy: cellular and molecular mechanisms. J Pathol. 2010 May;221(1):3–12.
  • Watson RO, Manzanillo PS, Cox JS. Extracellular M. tuberculosis DNA targets bacteria for autophagy by activating the host DNA-sensing pathway. Cell. 2012 Aug 17;150(4):803–815.
  • Manzanillo PS, Ayres JS, Watson RO, et al. The ubiquitin ligase parkin mediates resistance to intracellular pathogens. Nature. 2013 Sep 26;501(7468):512–516.
  • Franco LH, Nair VR, Scharn CR, et al. The ubiquitin ligase Smurf1 functions in selective autophagy of Mycobacterium tuberculosis and anti-tuberculous host defense. Cell Host Microbe. 2017 Jan 11;21(1):59–72.
  • Chauhan S, Kumar S, Jain A, et al. TRIMs and Galectins globally cooperate and TRIM16 and Galectin-3 co-direct autophagy in endomembrane damage homeostasis. Dev Cell. 2016 Oct 10;39(1):13–27.
  • Feng CG, Collazo-Custodio CM, Eckhaus M, et al. Mice deficient in LRG-47 display increased susceptibility to mycobacterial infection associated with the induction of lymphopenia. J Immunol. 2004 Jan 15;172(2):1163–1168.
  • Gutierrez MG, Master SS, Singh SB, et al. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell. 2004 Dec 17;119(6):753–766.
  • Singh SB, Davis AS, Taylor GA, et al. Human IRGM induces autophagy to eliminate intracellular mycobacteria. Science. 2006 Sep 8;313(5792):1438–1441.
  • The Wellcome Trust Case Control Consortium. Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. Nature. 2010 Apr 1;464(7289):713–720.
  • The Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007 Jun 7;447(7145):661–678.
  • Chauhan S, Mandell MA, Deretic V. IRGM governs the core autophagy machinery to conduct antimicrobial defense. Mol Cell. 2015 May 7;58(3):507–521.
  • Matsuzawa T, Kim BH, Shenoy AR, et al. IFN-gamma elicits macrophage autophagy via the p38 MAPK signaling pathway. J Immunol. 2012 Jul 15;189(2):813–818.
  • Kimmey JM, Huynh JP, Weiss LA, et al. Unique role for ATG5 in neutrophil-mediated immunopathology during M. tuberculosis infection. Nature. 2015 Dec 24;528(7583):565–569.
  • Martinez J, Almendinger J, Oberst A, et al. Microtubule-associated protein 1 light chain 3 alpha (LC3)-associated phagocytosis is required for the efficient clearance of dead cells. Proc Natl Acad Sci U S A. 2011 Oct 18;108(42):17396–17401.
  • Galluzzi L, Baehrecke EH, Ballabio A, et al. Molecular definitions of autophagy and related processes. Embo J. 2017 Jul 3;36(13):1811–1836.
  • Mitchell G, Isberg RR. Innate immunity to intracellular pathogens: balancing microbial elimination and inflammation. Cell Host Microbe. 2017 Aug 9;22(2):166–175.
  • Panneerdoss S, Viswanadhapalli S, Abdelfattah N, et al. Cross-talk between miR-471-5p and autophagy component proteins regulates LC3-associated phagocytosis (LAP) of apoptotic germ cells. Nat Commun. 2017 Sep 19;8(1):598.
  • Sanjuan MA, Dillon CP, Tait SW, et al. Toll-like receptor signalling in macrophages links the autophagy pathway to phagocytosis. Nature. 2007 Dec 20;450(7173):1253–1257.
  • Mehta P, Henault J, Kolbeck R, et al. Noncanonical autophagy: one small step for LC3, one giant leap for immunity. Curr Opin Immunol. 2014;26:69–75.
  • Henault J, Martinez J, Riggs JM, et al. Noncanonical autophagy is required for type I interferon secretion in response to DNA-immune complexes. Immunity. 2012 Dec 14;37(6):986–997.
  • Ma J, Becker C, Lowell CA, et al. Dectin-1-triggered recruitment of light chain 3 protein to phagosomes facilitates major histocompatibility complex class II presentation of fungal-derived antigens. J Biol Chem. 2012 Oct 5;287(41):34149–34156.
  • Bandyopadhyay U, Overholtzer M. LAP: the protector against autoimmunity. Cell Res. 2016 Aug;26(8):865–866.
  • Sprenkeler EG, Gresnigt MS. van de Veerdonk FL. LC3-associated phagocytosis: a crucial mechanism for antifungal host defence against Aspergillus fumigatus. Cell Microbiol. 2016 Sep;18(9):1208–1216.
  • Martinez J, Malireddi RK, Lu Q, et al. Molecular characterization of LC3-associated phagocytosis reveals distinct roles for Rubicon, NOX2 and autophagy proteins. Nat Cell Biol. 2015 Jul;17(7):893–906.
  • Ferwerda G, Girardin SE, Kullberg BJ, et al. NOD2 and toll-like receptors are nonredundant recognition systems of Mycobacterium tuberculosis. PLoS Pathog. 2005 Nov;1(3):279–285.
  • Koster S, Upadhyay S, Chandra P, et al. Mycobacterium tuberculosis is protected from NADPH oxidase and LC3-associated phagocytosis by the LCP protein CpsA. Proc Natl Acad Sci U S A. 2017 Oct 10;114(41):E8711–E8720.
  • Yuk JM, Shin DM, Lee HM, et al. Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell Host Microbe. 2009 Sep 17;6(3):231–243.
  • Shin DM, Yuk JM, Lee HM, et al. Mycobacterial lipoprotein activates autophagy via TLR2/1/CD14 and a functional vitamin D receptor signalling. Cell Microbiol. 2010 Nov;12(11):1648–1665.
  • Rekha RS, Rao Muvva SS, Wan M, et al. Phenylbutyrate induces LL-37-dependent autophagy and intracellular killing of Mycobacterium tuberculosis in human macrophages. Autophagy. 2015;11(9):1688–1699.
  • Verway M, Bouttier M, Wang TT, et al. Vitamin D induces interleukin-1beta expression: paracrine macrophage epithelial signaling controls M. tuberculosis infection. PLoS Pathog. 2013;9(6):e1003407.
  • Edfeldt K, Liu PT, Chun R, et al. T-cell cytokines differentially control human monocyte antimicrobial responses by regulating vitamin D metabolism. Proc Natl Acad Sci U S A. 2010 Dec 28;107(52):22593–22598.
  • Fabri M, Stenger S, Shin DM, et al. Vitamin D is required for IFN-gamma-mediated antimicrobial activity of human macrophages. Sci Transl Med. 2011 Oct 12;3(104):104ra102.
  • Chandra V, Bhagyaraj E, Nanduri R, et al. NR1D1 ameliorates Mycobacterium tuberculosis clearance through regulation of autophagy. Autophagy. 2015 Nov 2;11(11):1987–1997.
  • Kim YS, Lee HM, Kim JK, et al. PPAR-alpha activation mediates innate host defense through induction of TFEB and lipid catabolism. J Immunol. 2017 Apr 15;198(8):3283–3295.
  • Kim SY, Yang CS, Lee HM, et al. ESRRA (estrogen-related receptor alpha) is a key coordinator of transcriptional and post-translational activation of autophagy to promote innate host defense. Autophagy. 2018;14(1):152–168.
  • Hoyer-Hansen M, Bastholm L, Szyniarowski P, et al. Control of macroautophagy by calcium, calmodulin-dependent kinase kinase-beta, and Bcl-2. Mol Cell. 2007 Jan 26;25(2):193–205.
  • Yang CS, Kim JJ, Lee HM, et al. The AMPK-PPARGC1A pathway is required for antimicrobial host defense through activation of autophagy. Autophagy. 2014 May;10(5):785–802.
  • Kim TS, Shin YH, Lee HM, et al. Ohmyungsamycins promote antimicrobial responses through autophagy activation via AMP-activated protein kinase pathway. Sci Rep. 2017 Jun 13;7(1):3431.
  • Fan Y, Wang N, Rocchi A, et al. Identification of natural products with neuronal and metabolic benefits through autophagy induction. Autophagy. 2017 Jan 2;13(1):41–56.
  • Vingtdeux V, Giliberto L, Zhao H, et al. AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism. J Biol Chem. 2010 Mar 19;285(12):9100–9113.
  • Vingtdeux V, Chandakkar P, Zhao H, et al. Novel synthetic small-molecule activators of AMPK as enhancers of autophagy and amyloid-beta peptide degradation. FASEB J. 2011 Jan;25(1):219–231.
  • Stanley SA, Barczak AK, Silvis MR, et al. Identification of host-targeted small molecules that restrict intracellular Mycobacterium tuberculosis growth. PLoS Pathog. 2014 Feb;10(2):e1003946.
  • Zhang Q, Sun J, Wang Y, et al. Antimycobacterial and anti-inflammatory mechanisms of Baicalin via induced autophagy in macrophages Infected with Mycobacterium tuberculosis. Front Microbiol. 2017;8:2142.
  • Juarez E, Carranza C, Sanchez G, et al. Loperamide restricts intracellular growth of Mycobacterium tuberculosis in lung macrophages. Am J Respir Cell Mol Biol. 2016 Dec;55(6):837–847.
  • Chandra P, Rajmani RS, Verma G, et al. Targeting drug-sensitive and -resistant strains of Mycobacterium tuberculosis by inhibition of Src family kinases lowers disease burden and pathology. mSphere. 2016 Mar–Apr;1(2):e00043-15.
  • Schiebler M, Brown K, Hegyi K, et al. Functional drug screening reveals anticonvulsants as enhancers of mTOR-independent autophagic killing of Mycobacterium tuberculosis through inositol depletion. EMBO Mol Med. 2015 Feb;7(2):127–139.
  • Kim JJ, Lee HM, Shin DM, et al. Host cell autophagy activated by antibiotics is required for their effective antimycobacterial drug action. Cell Host Microbe. 2012 May 17;11(5):457–468.
  • Zheng Q, Wang Q, Wang S, et al. Thiopeptide antibiotics exhibit a dual mode of action against intracellular pathogens by affecting both host and microbe. Chem Biol. 2015 Aug 20;22(8):1002–1007.
  • Choi SW, Gu Y, Peters RS, et al. Ambroxol induces autophagy and potentiates rifampin antimycobacterial activity. Antimicrob Agents Chemother. 2018 Sep;62(9):e01019-18.
  • Liu PT, Krutzik SR, Modlin RL. Therapeutic implications of the TLR and VDR partnership. Trends Mol Med. 2007 Mar;13(3):117–124.
  • Liu PT, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006 Mar 24;311(5768):1770–1773.
  • Liu PT, Schenk M, Walker VP, et al. Convergence of IL-1beta and VDR activation pathways in human TLR2/1-induced antimicrobial responses. PLoS One. 2009 Jun 5;4(6):e5810.
  • Mily A, Rekha RS, Kamal SM, et al. Oral intake of phenylbutyrate with or without vitamin D3 upregulates the cathelicidin LL-37 in human macrophages: a dose finding study for treatment of tuberculosis. BMC Pulm Med. 2013 Apr 16;13:23.
  • Hardie DG, Ross FA, Hawley SA. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol. 2012 Mar 22;13(4):251–262.
  • Kim J, Kundu M, Viollet B, et al. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol. 2011 Feb;13(2):132–141.
  • Alers S, Loffler AS, Wesselborg S, et al. Role of AMPK-mTOR-Ulk1/2 in the regulation of autophagy: cross talk, shortcuts, and feedbacks. Mol Cell Biol. 2012 Jan;32(1):2–11.
  • Hoyer-Hansen M, Jaattela M. AMP-activated protein kinase: a universal regulator of autophagy? Autophagy. 2007 Jul–Aug;3(4):381–383.
  • Pal R, Palmieri M, Loehr JA, et al. Src-dependent impairment of autophagy by oxidative stress in a mouse model of Duchenne muscular dystrophy. Nat Commun. 2014 Jul;16(5):4425.
  • Kidwai S, Park CY, Mawatwal S, et al. Dual mechanism of action of 5-nitro-1,10-phenanthroline against Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2017 Nov;61(11):e00969-17.
  • Martineau AR, Timms PM, Bothamley GH, et al. High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Lancet. 2011 Jan 15;377(9761):242–250.
  • Daley P, Jagannathan V, John KR, et al. Adjunctive vitamin D for treatment of active tuberculosis in India: a randomised, double-blind, placebo-controlled trial. Lancet Infect Dis. 2015 May;15(5):528–534.
  • Tukvadze N, Sanikidze E, Kipiani M, et al. High-dose vitamin D3 in adults with pulmonary tuberculosis: a double-blind randomized controlled trial. Am J Clin Nutr. 2015 Nov;102(5):1059–1069.
  • Hasan Z, Salahuddin N, Rao N, et al. Change in serum CXCL10 levels during anti-tuberculosis treatment depends on vitamin D status [Short Communication]. Int J Tuberc Lung Dis. 2014 Apr;18(4):466–469.
  • Salahuddin N, Ali F, Hasan Z, et al. Vitamin D accelerates clinical recovery from tuberculosis: results of the SUCCINCT Study [Supplementary Cholecalciferol in recovery from tuberculosis]. A randomized, placebo-controlled, clinical trial of vitamin D supplementation in patients with pulmonary tuberculosis’. BMC Infect Dis. 2013 Jan 19;13:22.
  • Ganmaa D, Giovannucci E, Bloom BR, et al. Vitamin D, tuberculin skin test conversion, and latent tuberculosis in Mongolian school-age children: a randomized, double-blind, placebo-controlled feasibility trial. Am J Clin Nutr. 2012 Aug;96(2):391–396.
  • Martineau AR, Wilkinson RJ, Wilkinson KA, et al. A single dose of vitamin D enhances immunity to mycobacteria. Am J Respir Crit Care Med. 2007 Jul 15;176(2):208–213.
  • Ralph AP, Waramori G, Pontororing GJ, et al. L-arginine and vitamin D adjunctive therapies in pulmonary tuberculosis: a randomised, double-blind, placebo-controlled trial. PLoS One. 2013;8(8):e70032.
  • Mily A, Rekha RS, Kamal SM, et al. Significant effects of oral phenylbutyrate and vitamin D3 adjunctive therapy in pulmonary tuberculosis: A randomized controlled trial. PLoS One. 2015;10(9):e0138340.
  • Xing Y, Liqi Z, Jian L, et al. Doxycycline induces mitophagy and suppresses production of interferon-beta in IPEC-J2 cells. Front Cell Infect Microbiol. 2017;7:21.
  • Gao L, Tao Y, Zhang L, et al. Vitamin D receptor genetic polymorphisms and tuberculosis: updated systematic review and meta-analysis. Int J Tuberc Lung Dis. 2010 Jan;14(1):15–23.
  • Wallis RS, Zumla A. Vitamin D as adjunctive host-directed therapy in tuberculosis: A systematic review. Open Forum Infect Dis. 2016 Sep;3(3):ofw151.
  • Dimitrov V, White JH. Species-specific regulation of innate immunity by vitamin D signaling. J Steroid Biochem Mol Biol. 2016 Nov;164:246–253.
  • Ponpuak M, Davis AS, Roberts EA, et al. Delivery of cytosolic components by autophagic adaptor protein p62 endows autophagosomes with unique antimicrobial properties. Immunity. 2010 Mar 26;32(3):329–341.
  • Gomes MS, Paul S, Moreira AL, et al. Survival of Mycobacterium avium and Mycobacterium tuberculosis in acidified vacuoles of murine macrophages. Infect Immun. 1999 Jul;67(7):3199–3206.
  • Luong K, Nguyen LT. Impact of vitamin D in the treatment of tuberculosis. Am J Med Sci. 2011 Jun;341(6):493–498.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.